MedPath

To check irritation potential of the given samples (Patch test)

Phase 2
Completed
Conditions
skin patch test
Registration Number
CTRI/2019/11/022065
Lead Sponsor
ITC LIMITED ITC Life Sciences and Technology CENTRE
Brief Summary

Skin Irritation Test:

Irritants are substances that damage the skin. The damage will depend upon the nature, concentration and duration of exposure. Irritation is manifested as inflammatory responses such as erythema (redness), Oedema (swelling), and vesiculation and finally to an intense suppurate reaction without the involvement of the immune system. The irritation potential of a substance can be assessed by human patch test.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
35
Inclusion Criteria
  • 1.Volunteer (female/ male) in generally good health.
  • 2.Volunteer between the ages of 18 and 65 years.
  • Volunteer has not participated in a similar clinical investigation in the past four weeks.
  • Volunteer willing to give a written informed consent and come for regular observation.
  • 5.Subjects scoring greater than 30 for Section 2- Sensitive Vs Resistant skin in modified Dr. Baumann’s sensitive skin Questionnaire.
  • 6.Subject identified to have sensitive skin on basis of Dermatologist’s assessment of skin with fine texture and closeness of blood vessels to the surface.
Exclusion Criteria
  • A known history or present condition of allergic response to any cosmetic products.
  • Skin disease (e.g. psoriasis, atopic dermatitis or other cutaneous manifestations on the scalp), which would interfere with the test readings.
  • Subjects under chronic medication (e.g. Antihistamines, Antifungals, Corticosteroids, topical Steroids, etc.) that might influence the outcome of the study.
  • 4.Pregnant or lactating females.
  • 5.Subjects participating in any other cosmetic or therapeutic trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Irritation potentialfirst observation will be made at 30 minutes of patch removal (0 hr. observation). The further observations will be at 24 hrs and 1 week of patch removal
Secondary Outcome Measures
NameTimeMethod
investigational products to be tested for irritancy testOn each subject’s back one patch of each investigational product will be applied on Day 1. This will be 9 days study. For all the products and positive control the subjects will be assessed by the study dermatologist on Day 1 (Day of patch application), Day 2 (0 hrs. of patch removal i.e. 24 hrs. of patch application), Day 3 (24 hrs. of patch removal) and Day 9 (1 week after patch removal).

Trial Locations

Locations (1)

The KETs Scientific Research Centre

🇮🇳

(Suburban), MAHARASHTRA, India

The KETs Scientific Research Centre
🇮🇳(Suburban), MAHARASHTRA, India
Ms Meghana Surve
Principal investigator
02225639644
meghana@kelkarcosmetology.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.